Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
13,592,200
-
Share change
-
-224,470
-
Total reported value
-
$481,004,726
-
Put/Call ratio
-
2.2%
-
Price per share
-
$35.39
-
Number of holders
-
153
-
Value change
-
-$8,432,726
-
Number of buys
-
66
-
Number of sells
-
67
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q3 2020
As of 30 Sep 2020,
Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,592,200 shares.
The largest 10 holders included
BlackRock Inc., KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Avidity Partners Management LP, Boston Trust Walden Corp, and Baird Financial Group, Inc..
This page lists
153
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.